Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD)

BioEssays

Volumn 25, Issue 9, 2003, Pages 868-877

  McCracken, Ardythe A ^a   Brodsky, Jeffrey L ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AQUAPORIN 2; BETA N ACETYLHEXOSAMINIDASE; CD4 ANTIGEN; CELL PROTEIN; COLLAGEN; FIBRINOGEN; GAP JUNCTION PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOPHENOL MONOOXYGENASE; MUTANT PROTEIN; MYELOPEROXIDASE; PARATHYROID HORMONE RELATED PROTEIN; PROTEASOME; RHODOPSIN; THYROGLOBULIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; UNFOLDED PROTEIN;

AMINO ACID SUBSTITUTION; BIOMEDICINE; CATALYSIS; CATALYST; CELL SURVIVAL; CYTOSOL; ENDOPLASMIC RETICULUM; HUMAN; METABOLIC REGULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; QUALITY CONTROL; REVIEW;

ANIMALS; CELL MEMBRANE; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; CYTOSOL; ENDOPLASMIC RETICULUM; FUNGAL PROTEINS; GLYCOSYLATION; HUMANS; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT;

EID: 0042318739     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10320     Document Type: Review

References (107)

1. Patil C, Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol 2001;13:349-355.
2. Fewell SW, Travers KJ, Weissman JS, Brodsky JL. The action of molecular chaperones in the early secretory pathway. Annu Rev Genet 2001;35:149-191.
3. McCracken AA, Brodsky JL. Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP. J Cell Biol 1996;132:291-298.
4. Bukau B, Horwich AL. The Hsp70 and Hsp60 chaperone machines. Cell 1998;92:351-366.
5. Plemper RK, Bohmler S, Bordallo J, Sommer T, Wolf DH. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 1997;388:891-895.
6. Brodsky JL, Werner ED, Dubas ME, Goeckeler JL, Kruse KB, McCracken AA. The requirement for molecular chaperones during endoplasmic reticulum-associated protein degradation demonstrates that protein export and import are mechanistically distinct. J Biol Chem 1999;274:3453-3460.
7. Gillece P, Luz JM, Lennarz WJ, de La Cruz FJ, Romisch K. Export of a cysteine-free misfolded secretory protein from the endoplasmic reticulum for degradation requires interaction with protein disulfide isomerase. J Cell Biol 1999;147:1443-1456.
8. Molinari M, Galli C, Piccaluga V, Pieren M, Paganetti P. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J Cell Biol 2002;158:247-257.
9. Skowronek MH, Hendershot LM, Haas IG. The variable domain of nonassembled Ig light chains determines both their half-life and binding to the chaperone BiP. Proc Natl Acad Sci USA 1998;95:1574-1578.
10. Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 1999;286:1888-1893.
11. Nishikawa SI, Fewell SW, Kato Y, Brodsky JL, Endo T. Molecular chaperones in the yeast endoplasmic reticulum maintain the solubility of proteins for retrotranslocation and degradation. J Cell Biol 2001;153:1061-1070.
12. Kabani M, Kelley SS, Morrow MW, Montgomery DL, Sivendran R, Rose MD, Gierasch LM, Brodsky JL. Dependence of endoplasmic reticulum associated degradation (ERAD) on the peptide binding domain and concentration of BiP. Mol Biol Cell 2003, In press.
13. Vanhove M, Usherwood YK, Hendershot LM. Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release. Immunity 2001;15:105-114.
14. Cabral CM, Liu Y, Sifers RN. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci 2001;26:619-624.
15. Caramelo JJ, Castro OA, Alonso LG, De Prat-Gay G, Parodi AJ. Inaugural Article: UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates. Proc Natl Acad Sci USA 2003;100:86-89.
16. Parodi AJ. Protein glucosylation and its role in protein folding. Annu Rev Biochem 2000;69:69-93.
17. Braakman I. A novel lectin in the secretory pathway. An elegant mechanism for glycoprotein elimination. EMBO Rep 2001;2:666-668.
18. Oda Y, Hosokawa N, Wada I, Nagata K. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 2003;299:1394-1397.
19. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 2003;299:1397-1400.
20. Ihara Y, Cohen-Doyle MF, Saito Y, Williams DB. Calnexin discriminate between protein conformational states and functions as a molecular chaperone in vitro. Mol Cell 1999;4:331-341.
21. Molinari M, Helenius A. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 2000;288:331-333.
22. Wiertz EJ, Mukherjee S, Ploegh HL. Viruses use stealth technology to escape from the host immune system. Mol Med Today 1997;3:116-123.
23. Pilon M, Schekman R, Römisch K. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 1997;16:4540-4548.
24. Friedlander R, Jarosch E, Urban J, Volkwein C, Sommer T. A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat Cell Biol 2000;2:379-384.
25. Haigh NG, Johnson AE. A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane. J Cell Biol 2002;156:261-270.
26. Hamman BD, Hendershot LM, Johnson AE. BiP maintains the permeability barrier of the ER membrane by sealing the lumenal end of the translocation pore before and early in translocation. Cell 1998;92:747-758.
27. Ooi CE, Weiss J. Bidirectional movement of a nascent polypeptide across microsomal membranes reveals requirements for vectorial translocation of proteins. Cell 1992;71:87-96.
28. Plemper RK, Deak PM, Otto RT, Wolf DH. Re-entering the translocon from the lumenal side of the endoplasmic reticulum. Studies on mutated carboxypeptidase yscY species. FEBS Lett 1999;443:241-245.
29. Caldwell SR, Hill KJ, Cooper AA. Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J Biol Chem 2001;276:23296-23303.
30. Vashist S, Kim W, Belden WJ, Spear ED, Barlowe C, Ng DTW. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J Cell Biol 2001;155:355-367.
31. Taxis C, Vogel F, Wolf DH. ER-Golgi traffic is a prerequisite for efficient ER degradation. Mol Biol Cell 2002;13:1806-1818.
32. Zuber C, Fan J, Guhl B, Parodi A, Fessler JH, Parker C, Roth J. Immunolocalization of UDP-glucose-: glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control. Proc Natl Acad Sci USA 2001;98:10710-10715.
33. Haynes CM, Caldwell S, Cooper AA. An HRD/DER-independent ER quality control mechanism involves Rsp5p-dependent ubiquitination and ER-Golgi transport. J Cell Biol 2002;158:91-101.
34. Bass J, Turck C, Rouard M, Steiner DF. Furin-mediated processing in the early secretory pathway: Sequential cleavage and degradation of misfolded insulin receptors. Proc Natl Acad Sci USA 2000;97:11905-11909.
35. Arvan P, Zhao X, Ramos-Castaneda J, Chang A. Secretory pathway quality control operating in Golgi, plasmalemmal and endosomal systems. Traffic 2002;3:771-780.
36. Spear ED, Ng DTW. Stress tolerance of misfolded carboxypeptidase Y requires maintenance of protein trafficking and degradative pathways. Mol Biol Cell 2003;14:2756-2767.
37. Greenfield JJ, High S. Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. J Cell Sci 1999;112:1477-1486.
38. Benharouga M, Haardt M, Kartner N, Lukacs GL. COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. J Cell Biol 2001;153:957-970.
39. Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998;143:1883-1898.
40. Hill K, Cooper AA. Degradation of unassembled Vphlp reveals novel aspects of the yeast ER quality control system. EMBO J 2000;19:550-561.
41. Gusarova V, Caplan AJ, Brodsky JL, Fisher EA. Apoprotein B degradation is promoted by the molecular chaperones hsp90 and hsp70. J Biol Chem 2001;276:24891-2900.
42. Zhang Y, Nijbroek G, Sullivan ML, McCracken AA, Watkins SC, Michaelis S, Brodsky JL. The Hsp70 molecular chaperone facilitates the ER associated protein degradation of the cystic fibrosis transmembrane conductance regulator in yeast, Mol Cell Biol 2001;12:1303-1314.
43. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-533.
44. Yoshida Y, Chiba T, Tokunaga F, Kawasaki H, Iwai K, Suzuki T, Ito Y, Matsuoka K, Yoshida M, Tanaka K, Tai T. E3 ubiquitin ligase that recognizes sugar chains. Nature 2002;418:438-442.
45. Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, Wolf DH, Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 2002;4:134-139.
46. de Virgilio M, Weninger H, Ivessa NE. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome. J Biol Chem 1998;273:9734-9743.
47. Shamu CE, Flierman D, Ploegh HL, Rapoport TA, Chau V. Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mol Biol Cell 2001;12:2546-2555.
48. Brooks P, Murray RZ, Mason GG, Hendil KB, Rivett AJ. Association of immunoproteasomes with the endoplasmic reticulum. Biochem J 2000;352:611-615.
49. Mayer TU, Braun T, Jentsch S. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J 1998;17:3251-3257.
50. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999;68:1015-1068.
51. Patel S, Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol 1998;8:65-71.
52. Braun BC, Glickman M, Kraft R, Dahlmann B, Kloetzel PM, Finley D, Schmidt M. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol 1999;1:221-226.
53. Werner ED, Brodsky JL, McCracken AA, Proteasome-dependent ER-associated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci USA 1996;93:13797-13801.
54. Bays NW, Hampton RY, Cdc48-Ufd1-Npl4; stuck in the middle with Ub. Curr Biol 2002;12:R366-R371.
55. Verma R, Chen S, Feldman R, Schieltz D, Yates J, Dohmen J, Deshaies RJ. Proteasomel proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity purified proteasome. Mol Biol Cell 2000;11:3425-3439.
56. Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S. Role of the ubiquitin-selective CDC48 (UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J 2002;21:615-621.
57. Lam YA, Lawson TG, Velayutham M, Zweier JL, Pickart CM. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 2002;416:763-767.
58. Teckman JH, Gilmore R, Perlmutter DH. Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2000;278:G39-G48.
59. Rape M, Hoppe T, Gorr I, Kalocay M, Richly H, Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 2001;107:667-677.
60. Hitchcock AL, Krebber H, Frietze S, Lin A, Latterich M, Silver PA. The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol Biol Cell 2001;12:3226-3241.
61. Walter J, Urban J, Volkwein C, Sommer T. Sec61p-independent degradation of the tail-anchored ER membrane protein Ubc6p. EMBO J 2001;20:3124-3131.
62. Liu CW, Corboy MJ, DeMartino GN, Thomas PJ. Endoproteolytic activity of the proteasome. Science 2003;299:408-411.
63. Lee C, Prakash S, Matouschek A. Concurrent translocation of multiple polypeptide chains through the proteasomal degradation channel. J Biol Chem 2002;277:34760-34765.
64. Weihofen A, Binns K, Lemberg MK, Ashman K, Martoglio B, Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 2002;296:2215-2218.
65. Mullins C, Lu Y, Campbell A, Fang H, Green N. A mutation affecting signal peptidase inhibits degradation of an abnormal membrane protein in Saccharomyces cerevisiae. J Biol Chem 1995;270:17139-17147.
66. Hampton RY. Proteolysis and sterol regulation. Annu Rev Cell Dev Biol 2002;18:345-378.
67. Cheng HH, Xu L, Kumagai H, Simoni RD. Oligomerization state influences the degradation rate of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem 1999;274:17171-17178.
68. 2+ homeostasis. J Cell Biol 2002;157:1017-1028.
69. Vashist S, Frank CG, Jakob CA, Ng DT. Two distinctly localized p-type ATPases collaborate to maintain organelle homeostasis required for glycoprotein processing and quality control. Mol Biol Cell 2002;13:3955-3966.
70. Bays NW, Gardner RG, Seelig LP, Joazeiro CA, Hampton RA. Hrd1/ Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation, Nature Cell Biol 2001;3:24-29.
71. Deak PM, Wolf DH. Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation. J Biol Chem 2001;276:10663-10669.
72. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem 2002;277:17377-17380.
73. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2003;298:1781-1785.
74. Chapple JP, Grayson C, Hardcastle AJ, Saliba RS, van der Spuy J, Cheetham ME. Unfolding retinal dystrophies: a role for molecular chaperones? Trends Mol Med 2001;7:414-421.
75. Saliba RS, Munro PM, Luthert PJ, Cheetham ME. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J Cell Sci 2002;115:2907-2918.
76. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem 2002;277:34150-34160.
77. Brodsky JL. Chaperoning the maturation of the cystic fibrosis transmembrane conductance regulator. Am J Physiol Lung Cell Mol Physiol 2001;281:L39-L42.
78. Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P, Lomas DA. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem 1999;274:9548-9555.
79. Lomas DA, Mahadev R. α1-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110:1585-1590.
80. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014-9018.
81. Sidhar SK, Lomas DA, Carrell RW, Foreman RC. Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. J Biol Chem 1995;270:8393-8396.
82. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem 2002;277:6771-6774.
83. Brennan SO, Wyatt J, Medicina D, Callea F, George PM. Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly → Arg mutation. Am J Pathol 2000;157:189-196.
84. Brennan SO, Maghzal G, Shneider BL, Gordon R, Magid MS, George PM. Novel fibrinogen gamma 375 Arg → Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002;36:652-658.
85. Teter K, Holmes RK. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect Immun 2002;70:6172-6179.
86. Deeks ED, Cook JP, Day PJ, Smith DC, Roberts LM, Lord JM. The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. Biochemistry 2002;41:3405-3413.
87. Tsai B, Rodighiero C, Lencer WI, Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 2001;104:937-948.
88. Wesche J, Rapak A, Olsnes S. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol. J Biol Chem 1999;274:34443-34449.
89. Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ. Viral immune evasion: a masterpiece of evolution. Immunogenetics 2002;54:527-542.
90. Furman MH, Ploegh HL, Tortorella D. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J Biol Chem 2002;277:3258-3267.
91. Wilkinson BM, Tyson JR, Stirling CJ. Ssh1p determines the translocation and dislocation capacities of the yeast endoplasmic reticulum. Dev Cell 2001;1:401-409.
92. Qu D, Teckman JH, Omura S, Perlmutter DH. Degradation of a mutant secretory protein, alphal-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. J Biol Chem 1996;271:22791-22795.
93. Marr N, Bichet DG, Hoefs S, Savelkoul PJ, Konings IB, De Mattia F, Graat MP, Arthus MF, Lonergan M, et al. Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus. J Am Soc Nephrol 2002;13:2267-2277.
94. Lau MM, Neufeld EF. A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase. J Biol Chem 1998;264:21376-21380.
95. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 1996;70:809-819.
96. Fitzgerald J, Lamande SR, Bateman JF. Proteasomal degradation of unassembled mutant type I collagen pro-alpha1(1) chains. J Biol Chem 1999;274:27392-27398.
97. VanSlyke JK, Deschenes SM, Musil LS. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol Biol Cell 2000;11:1933-1946.
98. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-430.
99. Imamura T, Haruta T, Takata Y, Usui I, Iwata M, Ishihara H, Ishiki M, Ishibashi O, Ueno E, Sasaoka T, Kobayashi M. Involvement of Heat Shock Protein 90 in the Degradation of Mutant Insulin Receptors by the Proteasome. J Biol Chem 1998;273:11183-11188.
100. Esser V, Russell DW. Transport-deficient mutations in the low density lipoprotein receptor. Alterations in the cysteine-rich and cysteine-poor regions of the protein block intracellular transport. J Biol Chem 1998;263:13276-13281.
101. Vahdati-Ben Arieh S, Laham N, Schechter C, Yewdell JW, Coligan JE, Ehrlich R. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 2002;101:2858-2864.
102. DeLeo FR, Goedken M, McCormick SJ, Nauseef WM. A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/ proteasome degradation. J Clin Invest 1998;101:2900-2909.
103. lmai Y, Soda M, Hatakeyama S, Akagi T, Hashikawa T, Nakayama KI, Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell 2002;10:55-67.
104. Meerovitch K, Wing S, Goltzman D. Proparathyroid Hormone-related Protein Is Associated with the Chaperone Protein BiP and Undergoes Proteasome-mediated Degradation. J Biol Chem 1998;273:21025-21030.
105. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targovnik HM, Camargo R, Hossain SA, Arvan P. Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996;98:2838-2844.
106. Halaban R, Cheng E, Zhang Y, Moellmann G, Hanlon D, Michalak M, Setaluri V, Hebert DN. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci USA 1997;94:6210-6215.
107. Payne AS, Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation. Proc Natl Acad Sci USA 1998;95:10854-10859.